Quotient Sciences

Arcinova is a provider of comprehensive contract development and manufacturing services tailored for global pharmaceutical and biotechnology companies. The company specializes in the drug development pathway, offering expertise in drug substance synthesis, manufacturing scale-up, drug product manufacturing, bioanalytical services, and radiolabelling synthesis. By leveraging an innovative and agile approach, Arcinova helps clients navigate project challenges, allowing them to bring life-changing medicines to market more quickly and cost-effectively. They collaborate with a diverse range of clients, including multinational corporations and emerging startups, to enhance patient care through advanced technology and integrated solutions.

Pharmaterials Ltd. is a contract research organization based in Reading, United Kingdom, that specializes in the optimization of drug substance physical forms, such as salts, polymorphs, and co-crystals. Founded in 2000, the company focuses on the development of preclinical and early phase formulations and the manufacture of materials for clinical trials. As a part of Quotient Sciences, Pharmaterials provides comprehensive services that include characterization and optimization of drug substances, along with global drug product supply capabilities. The company is dedicated to supporting the pharmaceutical industry through its expertise in formulation development and clinical trial material production.

Founded in 2002, QS Pharma specialises in the formulation development and manufacturing of small molecule drug products, and is capable of supporting customer programs through all stages of development and commercialisation. Of particular relevance is QS Pharma’s capability to work with high potency molecules, which is a fast-growing market need.

SeaView Research, Inc. is a clinical research organization based in Miami, Florida, specializing in clinical pharmacology testing and laboratory services for the pharmaceutical industry. Established in 1995, the company conducts a wide range of studies, including pharmacokinetic and pharmacodynamic evaluations, drug interaction studies, and first-in-man trials. It is equipped to perform various types of drug administration, such as oral, topical, and intravenous methods, and offers services related to multiple therapeutic areas, including diabetes, dermatology, and smoking cessation. SeaView Research also studies diverse populations, including healthy volunteers and specific demographic groups like the elderly and postmenopausal women. The organization emphasizes adherence to rigorous protocols while maintaining high standards of quality and timeliness in its research processes. As of 2017, SeaView Research operates as a subsidiary of Quotient Clinical Ltd.